Stephen Stout - Mar 6, 2024 Form 4 Insider Report for Shattuck Labs, Inc. (STTK)

Signature
/s/ Stephen Stout
Stock symbol
STTK
Transactions as of
Mar 6, 2024
Transactions value $
-$129,142
Form type
4
Date filed
3/8/2024, 05:40 PM
Previous filing
Jan 31, 2024
Next filing
May 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STTK Common Stock Options Exercise $16.3K +4.65K +5.86% $3.51 84K Mar 6, 2024 Direct
transaction STTK Common Stock Sale -$49K -4.65K -5.54% $10.53 79.3K Mar 6, 2024 Direct F1
transaction STTK Common Stock Options Exercise $23.1K +6.46K +8.14% $3.57 85.8K Mar 6, 2024 Direct
transaction STTK Common Stock Sale -$68K -6.46K -7.53% $10.53 79.3K Mar 6, 2024 Direct F1
transaction STTK Common Stock Sale -$51.5K -4.9K -6.17% $10.53 74.4K Mar 6, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STTK Stock Option (Right to Buy) Options Exercise $0 -4.65K -33.33% $0.00 9.3K Mar 6, 2024 Common Stock 4.65K $3.51 Direct F2
transaction STTK Stock Option (Right to Buy) Options Exercise $0 -6.46K -27.08% $0.00 17.4K Mar 6, 2024 Common Stock 6.46K $3.57 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023.
F2 The stock option was granted to the Reporting Person on September 8, 2022, one-third of which vested on September 8, 2023 and the remaining two-thirds of which will vest on September 8, 2024.
F3 The stock option was granted to the Reporting Person on January 25, 2023, one-quarter of which vested on January 10, 2024 and the remaining three-quarters of which will vest in approximately equal monthly installments through January 10, 2027.

Remarks:

General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer